In Vitro Diagnostics Market To Reach $128.18 Billion By 2033

In Vitro Diagnostic Market Growth & Trends

The global in vitro diagnostics market size is expected to reach USD 128.18 billion in 2033 and is projected to grow at a CAGR of 2.40% from 2026 to 2033. driven by the increasing geriatric population, COVID-19 pandemic, and technological advancements in diagnostics that are supporting its adoption. Technological advancements in terms of portability, accuracy, and cost-effectiveness are projected to be one of the high-impact rendering drivers. Technological advancements were further accelerated by the launch of COVID-19 IVD diagnostics and enhanced the adoption of instruments and consumables for technologies, such as PCR. Competitors in the market are increasingly adopting agreement and partnership strategies to maintain a constant flow of business for manufacturers & diagnostics for users.

These agreements are also a result of the harsh price containment strategies for government laboratories, which lowers the price in government settings. For instance, in April 2021, the Italian subsidiary of Seegene, Inc. received a USD 108.25 million tenders for public procurement for the supply of extraction reagents, as well as 7.15 million SARS-CoV-2 diagnostic tests. However, it increases the multiparty nature and complexity of the supply chain. The high prevalence of cancer and Cardiovascular Diseases (CVDs) globally is anticipated to drive diagnostic innovation to facilitate early diagnosis and meet the constantly evolving needs of consumers. Novel technologies, such as plasmonic PCR, are anticipated to commercially enter the market during the forecast period, influencing the business of existing products adversely.

 Request a free sample copy or view the report summary: In Vitro Diagnostics Market Report

In Vitro Diagnostics Market Report Highlights

• The reagent segment dominated the market and held the largest revenue share of 65.68% in 2025, driven by significant R&D efforts from leading market players aiming to develop innovative biomarker kits.

• The molecular diagnostics segment dominated the market and held the largest revenue share of 25.77% in 2025.

• Infectious diseases dominated the market in 2025. One major trend is the shift toward multiplex tests that detect multiple respiratory pathogens like Flu A/B, COVID-19, and RSV in a single panel.

• The other segment accounted for the largest revenue market share in 2025. This includes traditional clinical laboratories, hospital diagnostic departments, reference and centralized testing facilities, specialized public health labs, and other institutional diagnostic settings that support high-throughput and complex assays.

• Hospitals held the largest market share in 2025, owing to increased hospitalization, as doctors require diagnostic interpretation for further treatment.

• North America dominated the in vitro diagnostics market and accounted for a 47.27% share in 2025.

In Vitro Diagnostics Market Segmentation

Grand View Research has segmented the global in vitro diagnostics market on the basis of products, technology, application, test location, end use, and region:

In Vitro Diagnostics Product Outlook (Revenue, USD Billion, 2021 - 2033) (Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)

• Instruments

• Reagents

• Services

In Vitro Diagnostics Technology Outlook (Revenue, USD Billion, 2021 - 2033) (Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)

• Immunoassay

  • Instruments

  • Reagents

  • Services

• Hematology

  • Instruments

  • Reagents

  • Services

• Clinical Chemistry

  • Instruments

  • Reagents

  • Services

• Molecular Diagnostics

  • Instruments

  • Reagents

  • Services

• Coagulation

  • Instruments

  • Reagents

  • Services

• Microbiology

  • Instruments

  • Reagents

  • Services

• Others

  • Instruments

  • Reagents

  • Services

In Vitro Diagnostics Application Outlook (Revenue, USD Billion, 2021 - 2033) (Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)

• Infectious Diseases

• Diabetes

• Oncology

• Cardiology

• Nephrology

• Autoimmune Diseases

• Drug Testing

• Other applications

In Vitro Diagnostics Test Location Outlook (Revenue, USD Billion, 2021 - 2033) (Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)

• Point of Care

• Home-care

• Services

In Vitro Diagnostics End Use Outlook (Revenue, USD Billion, 2021 - 2033) (Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)

• Hospitals

• Laboratory

• Home Care

• Others

In Vitro Diagnostics Regional Outlook (Revenue, USD Billion, 2021 - 2033) (Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Spain

  • Italy

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players of In Vitro Diagnostics Market

• Abbott

• Bio-Rad Laboratories, Inc

• Siemens Healthineers AG

• BIOMÉRIEUX

• BD

• QIAGEN

• Quidel Corporation

• F. Hoffmann-La Roche Ltd.

• Danaher

• Quest Diagnostics Incorporated

• Agilent Technologies, Inc.